|
|
Curis, Inc. - Comparative Business Analysis Snapshot
Business Description
Curis, Inc.. The Group's principal activity is to discover and develop therapeutic drug regulatory pathways that control repair and regenerate human tissues and organs. The Group's product development involves using proteins or small molecules to modulate these pathways, so as to increase the pathway signals when they are insufficient or decrease them when they are excessive. The Group has used this technology and product development strategy to produce several drug product candidates in the fields of kidney disease, neurological disorders, cancer, cardiovascular disease and hair growth regulation. The trademark of the Group is CurisTMand.
Competitor Analysis
This analysis compares Curis, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
